The Fortune 500 pharma giant will sequence the exomes of 10 million people, with the goal of developing new therapies and ...

Thus far 2025 has come roaring in as far as large rounds go. Last week more than a dozen companies raised $100 million or ...

Check out who's buying and selling in this week's roundup of healthcare mergers, acquisitions and joint ventures.

TauRx Pharma's effort to bring a tau-targeting drug for Alzheimer's disease (AD) to market has been a marathon, with a number of setbacks over the years, but the company reckons it may finally be ...

Investors in TauRx Pharma have exercised warrants worth around $119 million, adding to the biotech's financial resources as it prepares regulatory filings for tau-targeting Alzheimer's drug ...